May 2, 2019
Gilead net income $2B
@GileadSciences said Thursday its total revenues were $5.3 billion in 2019 compared to $5.1 billion in 2018, with net income of $2.0 billion compared to $1.5 billion in 2018.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
May 2, 2019
Sanofi’s dengue vaccine approved in USA
Sanofi’s dengue vaccien Dengvaxia was approved in the USA, the company said in a press release Thursday.
May 2, 2019
Axial Biotherapeutics develops AB-2004 as potential treatment for gastrointestinal dysfunction
– Preclinical results support development of AB-2004 as potential treatment for gastrointestinal dysfunction and associated behavioral symptoms of Autism Spectrum…
May 2, 2019
FSD Pharma delays 2018 Year-End Filings, working with new auditing firm in advance of listing on the NYSE
FSD Pharma delays 2018 Year-End Filings, working with new auditing firm in advance of listing on the NYSE
May 2, 2019
Vivera Pharmaceuticals names new Chief Medical Officer
NEWPORT BEACH, Calif.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CBD?src=hash” target=”_blank”gt;#CBDlt;/agt;–Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announced the appointment…
May 2, 2019
Teva posts $4.3 billion revenue in first quarter 2019
Revenues of $4.3 billion GAAP diluted loss per share of $0.10 Non-GAAP diluted EPS of $0.60 Free cash flow of…
May 2, 2019
Celgene and bluebird bio happy with expansion and persistence ofthe CAR T-cells seen in Phase 1 Study
Cellgene and bluebird bio are are encouraged by the expansion and persistence ofthe CAR T-cells, as well as the deep and durable responses with amanageable safety profile we’ve seen for bb2121 to date
May 2, 2019
Lilly presents new Emgality data
Eli Lilly will present 19 scientific abstracts for headache preventive drug Emgality (galcanezumab-gnlm) and lasmiditan at the 71st Annual Meeting of the American Academy of Neurology (AAN) taking place in Philadelphia from May 4-10, 2019.
May 2, 2019
Ironwood posts positive 2019 adjusted EBITDA from continuing operations guidance
– Ironwood launches as GI-focused healthcare company following separation of Cyclerion Therapeutics on April 1, 2019 – – First quarter…
May 2, 2019
GlycoMimetics ends first quarter 2019 with $195.6 million cash
Enrolled first patient in National Cancer Institute (NCI)-sponsoredPhase 3 trial of uproleselan in older adults with previously untreatedacute myeloid leukemia (AML)